Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 63 for “"Intranasal delivery"”.
-
Surface Engineering of Protein Nanoparticles for Intranasal Delivery
Intranasal delivery of vaccines offers a promising alternative approach to invasive intramuscular injection, with additional benefits such as inducing mucosal antibodies and cellular responses to neutralize pathogens before entering systemic circulation. However, nasal secretions and mucosa are …
-
Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines
… Despite the effectiveness of these drugs, the delivery routes are not ideal for first-line, outpatient treatments. A skilled caregiver must be present to administer drugs intravenously, and the social stigma associated with rectal administration results in low compliance. Intranasal delivery is …
-
Intranasal delivery of therapeutics targeted to CSF and Brain
… fluid barrier limit the systemic delivery of therapeutics to the brain and cerebrospinal fluid (CSF) respectively. Therapeutic agents targeting CNS are currently being administered by invasive routes which are not patient compliant and do not allow frequent administration. …
-
THERMAL STABILITY STUDY OF AQUEOUS OXTOCIN FORMULATION FOR INTRANASAL DELIVERY
… immediately available. In the present studies, intranasal delivery of oxytocin in aqueous micellar formulation is explored. Thermal stability of these formulations was evaluated and micellar formulation with sucrose laurate demonstrated enhanced thermal stability of oxytocin.
-
MODIFIED TLR7/8 ADJUVANTED LIPOSOMES FOR IMPROVED INTRANASAL DELIVERY OF SUBUNIT VACCINES
Intranasal vaccines hold enormous potential for improving vaccine efficacy against respiratory pathogens by activating the mucosal immune system. The urgency for novel approaches in vaccine development is amplified by the recent COVID-19 pandemic. Most intranasal vaccines that were developed are …
-
MODIFIED TLR7/8 ADJUVANTED LIPOSOMES FOR IMPROVED INTRANASAL DELIVERY OF SUBUNIT VACCINES
Intranasal vaccines hold enormous potential for improving vaccine efficacy against respiratory pathogens by activating the mucosal immune system. The urgency for novel approaches in vaccine development is amplified by the recent COVID-19 pandemic. Most intranasal vaccines that were developed are …
-
The Intranasal Delivery of DNSP-11 and its Effects in Animal Models of Parkinson's Disease
… of Parkinson’s disease (PD) has been the delivery of compounds across the blood-brain barrier (BBB) to the central nervous system (CNS). While direct surgical infusion has been utilized to deliver compounds to the brain that don’t cross the BBB, issues of poor biodistribution in the CNS …
-
Accelerating development of treatments for trigeminal neuralgia using intranasal delivery and a novel behavioral screening device for rats.
… orofacial and brain structures involved. Intranasal administration targets these structures while minimizing systemic exposure and side effects. Lidocaine was intranasally administered to rats, and the trigeminal nerve and trigeminally-innervated structures (teeth, temporomandibular joint …
-
Highly Tunable and Degradable Hydrophobized Nanogels for the Intranasal Delivery of Poorly-Water Soluble Antipsychotic Drugs to the Brain
… which can be exploited to create tunable drug delivery systems. The ability to alter the composition and structure of nanogels imparts advantageous characteristics for targeted drug delivery applications. Antipsychotic drugs (APDs) used to treat schizophrenia, a chronic neuropsychiatric …
-
Investigation of the intranasal delivery method as a means of targeting therapeutic agents to the Injured retina and optic nerve.
… This study examined the viability of the intranasal delivery method as a means of targeting therapeutic agents to the injured retina and optic nerve.
-
Effect of Intranasal Delivery of Carbon Dioxide on Trigeminal Ganglion Neurons: Inhibition of Neuron-Glia Gap Junction Communication and Neuropeptide Secretion
… from recent clinical trails have reported that intranasal administration of non-inhaled 100% medical grade CO2 is an effective and safe treatment for migraine and allergic rhinosinusitis, but the exact mechanism of action of CO2 in treating these diseases is not well understood. Activation of …
-
Assessing the innate and adaptive immunity response elicited by an intranasal therapeutic Mycobacterium tuberculosis stringent response vaccine targeting dendritic cells
… robust systemic and local Th1/Th17 responses of intranasal delivery of the MIP-3α/relMtb fusion vaccine (fusion vaccine) when combined with isoniazid compared to intramuscular delivery of the MIP-3α/relMtb fusion vaccine, intramuscular delivery of the relMtb vaccine (non-fusion vaccine), and …
-
Surface Engineering of Protein Nanoclusters to Overcome Mucus Barriers
Intranasal delivery of vaccines is a needle-free route that can induce mucosal antibodies and cellular responses to neutralize pathogens before entering systemic circulation, as well as systemic immunity. However, nasal secretions and mucosa are biological barriers that have been shown to inhibit …
-
Hydrogel-Based Intranasal Drug Delivery Platforms
… for oral or injectable antipsychotic drug delivery typically demonstrate low bioavailability to targeted brain regions, incentivizing the development of novel delivery strategies. Delivery via the nasal cavity circumvents multiple barriers to the reaching the brain: the blood-brain barrier, …
-
Identification of the brain areas that mediate insulin action
… cognition and memory. Interestingly, in humans, intranasal delivery of insulin to specifically target the brain, has an effect on feeding behaviour, glucose regulation and cognition. However, the action of intranasally administered insulin in the brain has not yet been fully explained, especially …
-
Optimising DNA vaccine technology to prevent HIV-1 infection.
… must first be optimised to improve both delivery and immunogenicity. In this thesis I have proposed two novel approaches to optimise DNA vaccines. Firstly, to improve delivery, I have proposed the use of influenza virosomes as a delivery vehicle for the intranasal administration of DNA …
-
Strategies to improve BCG-mediated protection from <i>Mycobacterium tuberculosis</i>
… in BALB/c and C57BL/6 mice. A comparison of intranasal and parenteral immunisation of BCG showed that whilst both routes elicited comparable T cell responses in the spleen, only intranasal delivery elicited specific T cell responses in the lung lymph nodes and these responses were further …
-
TARGETING CLEC9A ON DENDRITIC CELLS TO ACHIEVE ROBUST, BROAD, AND DURABLE SYSTEMIC AND MUCOSAL IMMUNITY AGAINST SARBECOVIRUS
… immunity and strong mucosal responses following intranasal delivery. Overall, Clec9A-targeted RBD vaccines demonstrate enhanced breadth, durability, and mucosal protection, offering a promising strategy to counter future sarbecovirus threats.
-
Design of Human Serum Albumin and Adenovirus Conjugation via Catcher/Tag Molecular Glue
Adenovirus (Ad) has been the ideal cargo delivery mechanism, and its moderate immunological response makes it ideal for in vivo gene therapies since its discovery in 1953. However, the robust immunogenicity of the Ad capsid and low vaccine absorption via mucous membranes and epithelium put a limit …
Page 1 of 4